CRISPR in Drug Discovery 2021

Speakers

Dr Andrew Bassett
Wellcome Sanger Institute
Dr Christopher Bryant
Wellcome Sanger Institute
Dr Tilmann Buerckstuemmer
Aelian Biotechnology
Austria
Antonio Carusillo
Center for Transfusion Medicine and Gene Therapy
Germany
Dr Sarah Cooper
Wellcome Sanger Institute
Prof Jacob Corn
ETH Zürich
Dr Paul Datlinger
CeMM Research Center for Molecular Medicine, Vienna
Dr Richard Davis
Leiden University Medical Center
Netherlands
Kam Dhaliwal
bit.bio
Ulrich Elling
Institute of Molecular Biotechnology, IMBA, Vienna
Mathew Garnett
Wellcome Sanger Institute
Zeev Gechtman
Abcam
Manuel Goncalves
LUMC
Stephen Hague
10x Genomics
Prof Alexis Komor
UCSD
Dr Madeline Lancaster
MRC Laboratory of Molecular Biology, Cambridge
Dr Carlos le Sage
Horizon Discovery Ltd
Prashant Mali
UCSD
Dr Klio Maratou
GlaxoSmithKline
Dr Marcello Maresca
AstraZeneca
Sweden
Dr Katia Mattis
IotaSciences
Dr Claudio Mussolino
University of Freiburg
Germany
Mr Pedro Ramos
i3S - IBMC; ICBAS
Portugal
Dr Greg Sienski
AstraZeneca
Sweden
Dr Lars Steinmetz
EMBL
Francesca Tasca
LUMC
Netherlands
Michael Ward
NIH/NINDS
Dr Kai Wilkens
Synthego
Germany